Phibro Animal Health Corp expected to post earnings of 28 cents a share - Earnings Preview

Phibro Animal Health

05/02/2024 21:03

* Phibro Animal Health Corp  PAHC.OQ   PAHC.O  is expected
to show
a fall in quarterly revenue when it reports  results on February
7 for the period ending December 31 2023
    * The Teaneck New Jersey-based  company is expected to
report a
0.9% decrease in revenue to $242.297 million from $244.6 million
a year ago, according to the mean estimate from 3 analysts,
based on LSEG data.
    * ​LSEG's mean analyst estimate for Phibro Animal Health
Corp is
for earnings of 28 cents per share. 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and 3 "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Phibro
Animal
Health Corp is $11.00​, above​ its last closing price of $10.63.
​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Sep. 30 2023  0.23        0.23       0.14      Missed  -39.1
 Jun. 30 2023  0.39        0.38       0.38      Met     -1.1
 Mar. 31 2023  0.33        0.34       0.29      Missed  -13.4​
 Dec. 31 2022  0.30        0.30       0.34      Beat    12.2
 ​​Sep.        0.27        0.27       0.21      Missed  -20.9
 30 2022                                                
 Jun. 30 2022  0.38        0.38       0.26      Missed  -32.1​
 Mar. 31 2022  0.35        0.35       0.33      Missed  -6.6
 Dec. 31 2021  0.32        0.33       0.37      Beat    13.3
 This summary was machine generated February 5 at 21:03 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)